Universe Pharmaceuticals Adjourns Shareholder Meeting Due to Lack of Quorum
Ticker: UPC · Form: 6-K · Filed: Feb 18, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Feb 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting, adjournment
TL;DR
Universe Pharma meeting postponed due to no-shows, rescheduled for Feb 19.
AI Summary
Universe Pharmaceuticals INC convened an extraordinary general meeting of shareholders on February 17, 2025. Due to a lack of quorum, the meeting was adjourned and rescheduled for February 19, 2025. The company is based in Ji'an, Jiangxi, China.
Why It Matters
Failure to achieve quorum can delay important corporate decisions and may indicate shareholder disengagement or dissatisfaction.
Risk Assessment
Risk Level: medium — Adjournment due to lack of quorum can signal underlying issues with shareholder engagement or corporate governance, potentially impacting future decisions.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the 6-K report
- February 17, 2025 (date) — Date of the initial extraordinary general meeting
- February 19, 2025 (date) — Rescheduled date for the extraordinary general meeting
- Ji'an, Jiangxi, China (location) — Company's principal executive offices
FAQ
What was the primary reason for the adjournment of the February 2025 Extraordinary General Meeting?
The meeting was adjourned due to a lack of quorum.
When was the original extraordinary general meeting scheduled to take place?
The original meeting was scheduled for February 17, 2025.
What is the new date for the adjourned extraordinary general meeting?
The meeting has been adjourned to February 19, 2025.
What is the principal business address of Universe Pharmaceuticals INC?
The principal business address is 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China, 343100.
Does Universe Pharmaceuticals INC file annual reports under Form 20-F?
Yes, the registrant indicates it files or will file annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 18, 2025 regarding Universe Pharmaceuticals INC (UPC).